Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRL757 PK in Healthy Elderly Volunteers
NCT06699628Phase 1Completed
- Sponsor
- IRLAB
- Start
- Sep 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of IRL757 in apathy (2 arms), sponsored by IRLAB. Primary endpoints: Maximum Plasma Concentration at 48 hours, Area Under the Curve at 48 hours and 3 more. Started Sep 2024; status: completed.
02
Drugs
IRL757
03
Conditions
apathy
Beyond the preview
Go deeper on NCT06699628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06699628.